Home/Filings/4/0000899243-21-004516
4//SEC Filing

TOMBESI PAOLO 4

Accession 0000899243-21-004516

CIK 0001571498other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 9:07 PM ET

Size

7.8 KB

Accession

0000899243-21-004516

Insider Transaction Report

Form 4
Period: 2021-02-01
TOMBESI PAOLO
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-01+124,239124,239 total
    Exercise: $11.02Exp: 2031-01-31Common Stock (124,239 underlying)
  • Award

    Common Stock

    2021-02-01+26,04154,486 total
Footnotes (4)
  • [F1]Plan. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in four equal annual installments over four years from the grant date, with the first installment vesting on February 1, 2022.
  • [F2]The reporting person acquired 996 shares of Common Stock under the Issuer's 2013 Employee Stock Purchase Plan (the "2013 ESPP") on February 29, 2020 that were not previously reported on Form 4.
  • [F3]The reporting person acquired 543 shares of Common Stock under the 2013 ESPP on August 31, 2020.
  • [F4]This option was granted on February 1, 2021 pursuant to the Company's 2013 Stock Incentive Plan with respect to 124,239 shares of Common Stock, with 25% vesting on February 1, 2022 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeother

Related Parties

1
  • filerCIK 0001707648

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 9:07 PM ET
Size
7.8 KB